XML 30 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity
12 Months Ended
Dec. 31, 2020
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
8. Stockholders’ Equity

Common Stock


At the Annual Meeting of our Company held on September 29, 2020, stockholders approved a proposal to increase the number of authorized shares of our common stock to 25,000,000 shares. Accordingly, on November 5, 2020, we filed an amendment to the Neonode Inc. Restated Certificate of Incorporation, as amended (our “Certificate of Incorporation”), with the Secretary of State of the State of Delaware to increase the number of authorized shares of our common stock to 25,000,000 shares.


On December 29, 2020, we issued 37,288 shares of our common stock to key employees pursuant to our 2020 long-term incentive program (“2020 LTIP”) – see Note 9.


Warrants and Other Common Stock Activity


During the year ended December 31, 2020, 325,000 warrants expired and no warrants were exercised. During the year ended December 31, 2019, warrants to purchase 360,000 shares of common stock were exercised for proceeds of $36,000.


A summary of all warrant activity is set forth below:


Outstanding and exercisable  Warrants   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Life
 
January 1, 2019   1,116,368   $10.18    2.68 
Exercised   (360,000)   0.10    - 
December 31, 2019   756,368   $14.98    1.47 
Issued   -    -    - 
Expired/forfeited   (325,000)   20.00    - 
Exercised   -    -    - 

December 31, 2020

   431,368   $11.20    1.13 

Outstanding Warrants to Purchase Common Stock as of December 31, 2020:


Description  Issue Date  Exercise
Price
   Shares   Expiration
Date
               
August 2016 Purchase Warrants  08/17/16  $11.20    431,368   02/17/22

Preferred Stock


During the year ended December 31, 2019, the only shares of our preferred stock issued and outstanding were Series B Preferred Stock. Effective July 1, 2019, all outstanding shares of our Series B Preferred Stock were converted into shares of our common stock.


On August 6, 2020, in connection with the closing of the Private Placement, the Company designated (i) 365 shares of its authorized and unissued preferred stock as Series C-1 Preferred Stock by filing a Series C-1 Certificate of Designation of Preferences, Rights and Limitations with the Secretary of State of the State of Delaware and (ii) 4,084 shares of its authorized and unissued preferred stock as Series C-2 Preferred Stock by filing a Series C-2 Certificate of Designation of Preferences, Rights and Limitations with the Secretary of State of the State of Delaware.


On September 24 and 29, 2020, respectively, the Series C-1 Preferred Stock and Series C-2 Preferred Stock (together, the “Series C Preferred Shares”) were converted into 684,378 shares of Neonode common stock.


The holders of the Series C-1 and C-2 Preferred Shares were entitled to receive dividends at the rate per share of 5% per annum, totaling $33,000. As of December 31, 2020, all of the preferred dividends had been paid.


On December 7, 2020, we filed Certificates of Elimination with the Secretary of State of the State of Delaware to eliminate the Series A Preferred Stock, Series B Preferred Stock, Series C-1 Preferred Stock and Series C-2 Preferred Stock.


No shares of preferred stock were issued and outstanding as of December 31, 2020.


Details of the preferred stock activities are set forth below:


   Series B
Preferred
Stock
Shares
Issued
   Series B
Preferred
Stock
Amount
   Series C-1
Preferred
Stock
Shares
Issued
   Series C-1
Preferred
Stock
Amount
   Series C-2
Preferred
Stock
Shares
Issued
   Series C-2
Preferred
Stock
Amount
 
                         
Balances, December 31, 2018   82   $    -    -   $-    -   $- 
                               
Conversion of Series B Preferred Stock to common stock   (82)   -    -    -    -    - 
                               
Balances, December 31, 2019   -    -    -    -    -    - 
                               
Issuance of Preferred Shares for cash   -    -    365    365    3,567    3,567 
                               
Series C-2 Preferred Stock issued for repayment of short-term borrowings and accrued interest   -    -    -    -    517    517 
                               
Conversion of Preferred Shares to common stock   -    -    (365)   (365)   (4,084)   (4,084)
                               
Balances, December 31, 2020   -   $-    -   $-    -   $-